The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women

AJR. American Journal of Roentgenology
D S MayD S Miller

Abstract

We describe results from 284,503 mammographic examinations and associated diagnostic workups provided to medically underserved women in an ongoing nationwide breast cancer early detection program. We report the results of mammographic examinations and diagnostic workups on 230,143 medically underserved women 40 years old or older who underwent at least one mammographic examination from July 1991 through June 1995. Mammograms were obtained in hundreds of mammography and clinical facilities throughout the United States, including community health centers, health department clinics, private practitioners' offices, university based facilities, and mobile mammography units. Our analysis included rates of mammograms with abnormal findings (reported according to the categories of the American College of Radiology Breast Imaging Reporting and Data System), breast cancer detection rates, numbers of diagnostic procedures performed, stage and size distribution of breast cancers, and positive predictive value of mammograms and biopsies with abnormal findings--all presented according to screening round and 10-year age intervals. Mammograms with abnormal findings constituted 5% of mammograms in the first round and 4% in subsequent rounds, bo...Continue Reading

Citations

Oct 8, 1999·Disease-a-month : DM·K FordB Lum
Jul 26, 2000·Obstetrics and Gynecology·G F SawayaA E Washington
Apr 18, 2003·Seminars in Roentgenology·Liane E Philpotts, Robert A Smith
Apr 13, 1999·American Journal of Preventive Medicine·M E FernandezK R Stewart
Aug 2, 2003·Ethnicity & Health·Elizabeth L McGarveyBonita Pennino
Apr 10, 2004·Journal of Women's Health·Celia Patricia KaplanMaria Juarez-Reyes
Jan 4, 2001·Journal of the National Cancer Institute·N S Weiss
Jun 17, 2004·Journal of the National Cancer Institute·Gregory D Leonard, Sandra M Swain
Mar 3, 2005·Journal of the National Cancer Institute·Rebecca Smith-BindmanKarla Kerlikowske
Mar 12, 2005·Annual Review of Public Health·Nancy Breen, Helen I Meissner
Sep 26, 2007·Journal of Carcinogenesis·Farid Saleh, Suad Abdeen
May 16, 2007·World Journal of Surgical Oncology·George C ZografosJohn Bramis
Jan 12, 2000·American Journal of Public Health·A R FolsomC P Hong
Oct 16, 2004·Journal of General Internal Medicine·Timothy R DresselhausDan Bertenthal
Sep 16, 1998·Mayo Clinic Proceedings·J W Hampton
May 15, 2007·The Surgical Clinics of North America·Martin J O'Sullivan, Monica Morrow
Aug 16, 2000·Radiologic Clinics of North America·E A Sickles
Oct 20, 2010·Journal of the National Cancer Institute. Monographs·Etta D Pisano
Mar 6, 2015·Radiologia brasileira·Gustavo Machado BadanOzeas Alves de Noronha Junior
Oct 9, 2002·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Edward C MansleyMatthew T McKenna
May 26, 2004·Public Health Reports·Ross C Brownson, Frank S Bright
Dec 9, 2008·The Journal of the Royal Society for the Promotion of Health·Shin-Jong Lin
Mar 8, 2000·Cancer·C R Baquet, P Commiskey
Apr 26, 2002·Cancer Practice·Kathleen EllPey-Jiuan Lee
Jul 13, 2002·Cancer·Laura LibermanD David Dershaw
Apr 19, 2007·Journal of Women's Health·Diane M MakucAlan Cohen
Mar 3, 2004·Obstetrics and Gynecology·Vicki B BenardNancy C Lee
Nov 17, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Isabella CastellanoAnna Sapino
May 30, 2003·Medical Care·Cathy J BradleyCaralee Roberts

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.